# Vertex Ventures' Biotech Investments: 13 Startups in Its Portfolio (2026)

> The 13 Biotech startups Vertex Ventures has backed, by stage: $2.2B raised between them. From the rounds we track; updated nightly.

Source: https://millionrounds.com/portfolio-maps/vertex-ventures-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article)

## Series C and later

5

- [ElevateBio](https://millionrounds.com/company/elevatebio)
- [Obsidian Therapeutics](https://millionrounds.com/company/obsidian-therapeutics)
- [Boundless Bio](https://millionrounds.com/company/boundless-bio)
- [Moximed](https://millionrounds.com/company/moximed)
- [Visterra](https://millionrounds.com/company/visterra)

## Series B

4

- [Matchpoint Therapeutics](https://millionrounds.com/company/matchpoint-therapeutics)
- [Harbour BioMed](https://millionrounds.com/company/harbour-biomed)
- [Palleon Pharmaceuticals](https://millionrounds.com/company/palleon-pharmaceuticals)
- [*UH* United Health](https://millionrounds.com/company/united-health)

## Stage not reported

2

- [EarLens](https://millionrounds.com/company/earlens)
- [Nuvaira](https://millionrounds.com/company/nuvaira)

## Series A

2

- [*E* Eyebiotech](https://millionrounds.com/company/eyebiotech)
- [*2T* 27-8 Therapeutics](https://millionrounds.com/company/27-8-therapeutics)

## Segment by segment

### Series C and later

5 startups · $1.2B raised

- [**ElevateBio**](https://millionrounds.com/company/elevatebio) ElevateBio is a biotechnology company based in Waltham, Massachusetts, founded in 2017. United States $551M
- [**Obsidian Therapeutics**](https://millionrounds.com/company/obsidian-therapeutics) Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy. United States $210M
- [**Boundless Bio**](https://millionrounds.com/company/boundless-bio) Boundless Bio is a precision oncology company that develops therapeutics directed against extrachromosomal DNA in aggressive cancers. United States $146M
- [**Moximed**](https://millionrounds.com/company/moximed) Moximed Inc. United States $146M
- [**Visterra**](https://millionrounds.com/company/visterra) Visterra researches on and develops therapeutic and diagnostic products for the treatment of infectious diseases. United States $120M

### Series B

4 startups · $517M raised

- [**Matchpoint Therapeutics**](https://millionrounds.com/company/matchpoint-therapeutics) Matchpoint Therapeutics is a biotechnology company based in Cambridge, Massachusetts, founded in 2021. United States $220M
- [**Harbour BioMed**](https://millionrounds.com/company/harbour-biomed) Harbour BioMed is a clinical stage biopharmaceutical company developing innovative therapeutics in the fields of immuno-oncology. China $190M
- [**Palleon Pharmaceuticals**](https://millionrounds.com/company/palleon-pharmaceuticals) Palleon Pharmaceuticals is a clinical-stage biotechnology company based in Waltham, Massachusetts. United States $100M
- [*UH* **United Health**](https://millionrounds.com/company/united-health) Beijing Zhongliankang Biological Technology China $6.7M

### Stage not reported

2 startups · $363M raised

- [**EarLens**](https://millionrounds.com/company/earlens) Earlens is a medical technology company transforming the hearing experience with the only direct sound delivery system. United States $248M
- [**Nuvaira**](https://millionrounds.com/company/nuvaira) Nuvaira is a new alternative COPD treatment option that specializes in developing devices for treating lung diseases. United States $115M

### Series A

2 startups · $130M raised

- [*E* **Eyebiotech**](https://millionrounds.com/company/eyebiotech) Eyebiotech is an ophthalmology biotechnology company that specializes in therapies for eye diseases. United States $65M
- [*2T* **27-8 Therapeutics**](https://millionrounds.com/company/27-8-therapeutics) United States $65M

**How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names Vertex Ventures as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

## More portfolio maps

[All portfolios](https://millionrounds.com/portfolio-maps)

[Sector portfolio **Vertex Ventures' AI portfolio** 31 startups · $1.3B](https://millionrounds.com/portfolio-maps/vertex-ventures-ai-portfolio)[Portfolio map **Vertex Ventures portfolio map** 106 startups · $8.5B](https://millionrounds.com/portfolio-maps/vertex-ventures-portfolio-map)[Co-investors **Who invests with Vertex Ventures** 100 co-investors](https://millionrounds.com/portfolio-maps/vertex-ventures-co-investors)[Investments abroad **Vertex Ventures' investments in the United States** 62 startups · $4.5B](https://millionrounds.com/portfolio-maps/vertex-ventures-investments-united-states)[Investments abroad **Vertex Ventures' investments in China** 15 startups · $1.1B](https://millionrounds.com/portfolio-maps/vertex-ventures-investments-china)[Sector portfolio **Nascent's Web3 & Crypto portfolio** 16 startups · $85M](https://millionrounds.com/portfolio-maps/nascent-web3-crypto-portfolio)

## Raising from investors like Vertex Ventures?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

[Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)
